SPRO - Spero Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.34
-0.03 (-0.29%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close10.37
Open10.37
Bid0.00 x 900
Ask0.00 x 900
Day's Range9.94 - 10.50
52 Week Range5.52 - 14.48
Volume30,211
Avg. Volume66,449
Market Cap181.196M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?
    Simply Wall St.13 days ago

    Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?

    It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

  • Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates
    Zacks2 months ago

    Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates

    Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 62.34% and 517.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for
    Zacks3 months ago

    Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for

    Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Marriott Is Officially Getting Into the Homesharing Business
    Skift3 months ago

    Marriott Is Officially Getting Into the Homesharing Business

    Marriott, the world's largest hotel company with more than 7,000 hotels around the world, is officially getting into the homesharing business with the launch of Homes & Villas by Marriott International in 100 destinations. A year after it began conducting a homesharing pilot, the 91-year-old hotel group appears convinced it can compete with travel disruptors […]The post Marriott Is Officially Getting Into the Homesharing Business appeared first on Skift.

  • Spero Gets Fast Track Designation for SPR994, Shares Improve
    Zacks4 months ago

    Spero Gets Fast Track Designation for SPR994, Shares Improve

    Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.

  • Will Spero Therapeutics Continue to Surge Higher?
    Zacks4 months ago

    Will Spero Therapeutics Continue to Surge Higher?

    As of late, it has definitely been a great time to be an investor in Spero Therapeutics.

  • Associated Press4 months ago

    Airbnb, HomeAway lose legal challenge to Santa Monica rules

    Short-term rental sites Airbnb and HomeAway lost a legal challenge Wednesday against an ordinance enacted by a popular California tourist city. The ordinance imposed several obligations involving rental sites in seaside Santa Monica, including refraining from booking properties that are not licensed and listed on a city registry. A 9th U.S. Circuit Court of Appeals panel ruled that a lower court properly dismissed the legal challenge over its failure to state a claim against the city.

  • Airbnb Loses Major Fight Over California City's Rental Law
    Bloomberg4 months ago

    Airbnb Loses Major Fight Over California City's Rental Law

    The ruling Wednesday by a three-judge panel of the Ninth Circuit is a setback for the home-sharing platforms in their effort to avoid regulation by cities that blame the rapid proliferation of short-term rentals for a shortage of affordable housing and a disintegration of residential communities. The Santa Monica ordinance holds the companies responsible for booking rentals of residences that aren’t licensed by the city. San Francisco-based Airbnb is the largest home-rental platform with more than 6 million listings around the world.

  • Are Spero Therapeutics, Inc.’s (NASDAQ:SPRO) Interest Costs Too High?
    Simply Wall St.5 months ago

    Are Spero Therapeutics, Inc.’s (NASDAQ:SPRO) Interest Costs Too High?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Spero Therapeutics, Inc. (NASDAQ:SPRO), which has zero-debt on its balanceRead More...

  • Expedia Analysts Grow More Bullish After Strong Earnings
    Bloomberg5 months ago

    Expedia Analysts Grow More Bullish After Strong Earnings

    While growth in Expedia’s home rental service disappointed, the company made up for it with strength in its core platform. Cowen also sees positive read-through to peers Booking Holdings Inc. and TripAdvisor Inc., which report later this month. “HomeAway was the major disappointment” in the fourth quarter and the lack of prior warning from management suggested it must have started to deteriorate at the end of the year, after third-quarter results.

  • Expedia Group Inc. (EXPE) Q4 2018 Earnings Conference Call Transcript
    Motley Fool5 months ago

    Expedia Group Inc. (EXPE) Q4 2018 Earnings Conference Call Transcript

    EXPE earnings call for the period ending December 31, 2018.

  • Expedia Shares Jump After 2019 Earnings Forecast Beats Estimates
    Bloomberg5 months ago

    Expedia Shares Jump After 2019 Earnings Forecast Beats Estimates

    Adjusted earnings before interest, tax, depreciation and amortization, will grow 10 percent to 15 percent in 2019, Chief Financial Officer Alan Pickerill said on a conference call Thursday. Analysts were projecting an increase of 9 percent, according to data compiled by Bloomberg. Analysts were looking for signs that Expedia’s performance would justify a runaway share price so far this year.

  • Benzinga6 months ago

    The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 7) Axsome Therapeutics Inc (NASDAQ: AXSM ) ( reported positive ...

  • DAFNA Capital Management Return, AUM and Holdings
    Insider Monkey7 months ago

    DAFNA Capital Management Return, AUM and Holdings

    DAFNA Capital Management, LLC is a Los Angeles-based hedge fund launched by Dr. Nathan Fischel, back in 1999. Dr. Fischel is an experienced Pediatric Hematologist-Oncologist, who graduated from the Technion School of Medicine in Israel and completed his residency at the Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston. For his post-graduate studies […]

  • Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss
    Zacks8 months ago

    Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss

    Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 6.25% and 0.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Expedia acquires Pillow and ApartmentJet to conquer the short-term rental market
    TechCrunch9 months ago

    Expedia acquires Pillow and ApartmentJet to conquer the short-term rental market

    To keep up with the rising demand for short-term rentals in U.S. cities and compete with the home-sharing giant Airbnb, travel booking site Expedia has picked up a pair of venture-backed hospitality startups, Pillow and ApartmentJet. Employees of both companies will join Expedia . "Acquiring Pillow and ApartmentJet will help unlock urban growth opportunities that, over time, will contribute to HomeAway's ability to add an even broader selection of accommodations to its marketplace and marketplaces across Expedia Group brands, ensuring travelers always find the perfect place to stay," the company explained in a statement.

  • Expedia Group (EXPE) Q3 Earnings Beat, Revenues Surge Y/Y
    Zacks9 months ago

    Expedia Group (EXPE) Q3 Earnings Beat, Revenues Surge Y/Y

    Expedia Group (EXPE) continues to benefit from the robust performance of HomeAway, Brand Expedia, Expedia Partner Solutions and Hotels.com in third-quarter 2018.

  • Reuters9 months ago

    UPDATE 2-Expedia beats profit estimates on HomeAway, travel bookings growth

    Expedia Group Inc saw major growth in its vacation rental business HomeAway and higher travel bookings in the third quarter, helping it to beat Wall Street's profit estimates on Thursday. Expedia said customers spent 24 percent more on HomeAway bookings and that the business, which competes with Airbnb, is headed for strong revenue and profit growth this year. Amobi, however, warned that the fourth quarter may not be as strong as the third and a key thing to watch would be whether Expedia is able to maintain this type of growth trajectory.

  • Expedia Inc Del (EXPE) Q3 2018 Earnings Conference Call Transcript
    Motley Fool9 months ago

    Expedia Inc Del (EXPE) Q3 2018 Earnings Conference Call Transcript

    EXPE earnings call for the period ending September 30, 2018.

  • Expedia Earnings Beat Estimates, Fueled by Home-Rentals Growth
    Bloomberg9 months ago

    Expedia Earnings Beat Estimates, Fueled by Home-Rentals Growth

    Analysts had predicted $3.10 a share, according to data compiled by Bloomberg. Expedia, which owns travel aggregator websites like Hotels.com, Hotwire.com and CarRentals.com, is starting to see the benefits of buying HomeAway three years ago. Expedia paid $3.9 billion in 2015 for the vacation-home rental site in a power play to rival upstart Airbnb Inc. Along with Booking Holdings Inc., the three have been battling to woo travelers and go beyond typical vacation packages to expand offerings in people’s homes in cities.

  • War against the superbugs: Mass. biotechs step up to fight antibiotic resistance
    American City Business Journals9 months ago

    War against the superbugs: Mass. biotechs step up to fight antibiotic resistance

    In a world where superbugs are overpowering various antibiotic drugs, threatening millions of lives, Massachusetts biotechs are fighting hard to ensure the bugs don't become the industry's kryptonite.

  • What's in the Cards for Expedia Group (EXPE) in Q3 Earnings?
    Zacks9 months ago

    What's in the Cards for Expedia Group (EXPE) in Q3 Earnings?

    Expedia Group (EXPE) Q3 results to benefit from well-performing segments that are likely to boost gross bookings.

  • The travel industry is extremely resilient, says Expedia CEO
    CNBC Videos5 months ago

    The travel industry is extremely resilient, says Expedia CEO

    Expedia President and CEO Mark Okerstrom joins "Squawk on the Street" to discuss the company's strong earnings and what the state of travel is for the United States and around the world.